On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...